NMES for COPD and Pneumonia

N/A

Recruiting

Led By Renee Stapleton, MD, PhD

Research Sponsored by University of Vermont

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Hospitalized for CAP and/or AECOPD

>50 years old

Must not have

New or existing intracranial, spinal, vascular, or neuromuscular condition limiting walking ability

Lower extremity impairments that prevent bilateral use of NMES (e.g., amputation, leg injury)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up enrollment, time of hospital discharge up to 6 weeks, 6 week follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial will test the feasibility and acceptability of using electrical stimulation to improve physical and cognitive recovery in older adults hospitalized for AECOPD/CAP.

Who is the study for?

This trial is for adults over 50 hospitalized with COPD or pneumonia, expected to stay at least two more days. They must be able to use NMES on both legs and not have severe skin issues, a BMI over 40, life expectancy under six months, certain heart devices, or be in ICU care. Participants should've been walking independently before admission.

What is being tested?

The study tests if neuromuscular electrical stimulation (NMES) can help older adults recover better from COPD/pneumonia. It starts in the hospital and continues at home for six weeks. Patients will use an NMES device on their legs daily and their recovery progress will be monitored through various assessments.

What are the potential side effects?

Potential side effects of NMES may include discomfort or pain at the stimulation site, muscle fatigue after treatment, skin irritation beneath electrode pads, and rarely muscle twitching during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am in the hospital for pneumonia or a severe COPD flare-up.

Select...

I am over 50 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a condition that affects my ability to walk.

Select...

I cannot use NMES on both legs due to an impairment like amputation or injury.

Select...

I have severe skin damage on my leg.

Select...

I was not walking on my own before being admitted to the hospital, but I can use a walking aid.

Select...

I have a blood clot in the deep veins of my leg.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ enrollment, time of hospital discharge up to 6 weeks, 6 week follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~enrollment, time of hospital discharge up to 6 weeks, 6 week follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment, time of hospital discharge up to 6 weeks, 6 week follow-up for reporting.